INDO US BIOTECH
Back to Cashflow Statement
|
INDO US BIOTECH Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1.42 Cr | ₹-4.58 Cr | ₹0.53 Cr | ₹2.91 Cr | ₹0.22 Cr |
What is the latest Cash Flow from Operating Activities ratio of INDO US BIOTECH ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹1.42 Cr |
| Mar2024 | ₹-4.58 Cr |
| Mar2023 | ₹0.53 Cr |
| Mar2022 | ₹2.91 Cr |
| Mar2021 | ₹0.22 Cr |
How is Cash Flow from Operating Activities of INDO US BIOTECH Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.42 Cr | Positive | |
| Mar2024 | ₹-4.58 Cr | Negative | |
| Mar2023 | ₹0.53 Cr | -81.91 | |
| Mar2022 | ₹2.91 Cr | 1,192.44 | |
| Mar2021 | ₹0.22 Cr | - | |
Compare Cash Flow from Operating Activities of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹178.9 Cr | -1.4% | -11.9% | -41.4% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,760.4 Cr | 9% | 3% | -26.5% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,997.8 Cr | -0.4% | -6.5% | -10.8% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,064.8 Cr | -3.4% | 2.2% | 8.2% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹926.6 Cr | -2.4% | -8.8% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹527.3 Cr | 1.6% | 17.7% | 13.6% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -1.4% |
-11.9% |
-41.4% |
| SENSEX | -0.4% |
0.8% |
-5.3% |
You may also like the below Video Courses